385 related articles for article (PubMed ID: 10554053)
21. Disodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia.
Ostenstad B; Andersen OK
Acta Oncol; 1992; 31(8):861-4. PubMed ID: 1290634
[TBL] [Abstract][Full Text] [Related]
22. Ibandronate.
Dooley M; Balfour JA
Drugs; 1999 Jan; 57(1):101-8; discussion 109-10. PubMed ID: 9951955
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
Pecherstorfer M; Steinhauer EU; Rizzoli R; Wetterwald M; Bergström B
Support Care Cancer; 2003 Aug; 11(8):539-47. PubMed ID: 12783289
[TBL] [Abstract][Full Text] [Related]
25. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Plosker GL; Goa KL
Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonates: biological response modifiers in breast cancer.
Paterson AH
Clin Breast Cancer; 2002 Aug; 3(3):206-16; discussion 217-8. PubMed ID: 12196279
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
Coleman RE
Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
[TBL] [Abstract][Full Text] [Related]
28. Treatment of cancer-related hypercalcemia: the role of gallium nitrate.
Leyland-Jones B
Semin Oncol; 2003 Apr; 30(2 Suppl 5):13-9. PubMed ID: 12776255
[TBL] [Abstract][Full Text] [Related]
29. Gallium nitrate.
Hughes TE; Hansen LA
Ann Pharmacother; 1992 Mar; 26(3):354-62. PubMed ID: 1554958
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
31. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
[TBL] [Abstract][Full Text] [Related]
32. Zoledronic acid.
Cheer SM; Noble S
Drugs; 2001; 61(6):799-805; discussion 806. PubMed ID: 11398911
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology and management of severe hypercalcemia.
Nussbaum SR
Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
[TBL] [Abstract][Full Text] [Related]
34. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
35. The diagnosis and management of hypercalcaemia.
Koh LK
Ann Acad Med Singap; 2003 Jan; 32(1):129-39. PubMed ID: 12625112
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy.
Sauty A; Pecherstorfer M; Zimmer-Roth I; Fioroni P; Juillerat L; Markert M; Ludwig H; Leuenberger P; Burckhardt P; Thiebaud D
Bone; 1996 Feb; 18(2):133-9. PubMed ID: 8833207
[TBL] [Abstract][Full Text] [Related]
37. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
Fleisch H
Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic hypercalcaemia in lung cancer.
Campbell JH; Ralston S; Boyle IT; Banham SW
Respir Med; 1991 May; 85(3):223-7. PubMed ID: 1831917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
